Daniel R. Kuritzkes, MD, on HIV Resistance After PrEP

In this podcast, Daniel R. Kuritzkes, MD, talks about HIV resistance in the context of pre-exposure prophylaxis (PrEP) use, how common it is, and how PrEP might influence subsequent therapies.

Additional Resource:

• Kuritzkes DR. HIV resistance in the context of PrEP. Talk presented at: 10th IAS Conference on HIV Science; July 21-25, 2019; Mexico City, Mexico. https://bit.ly/2KtvJa1.

Daniel R. Kuritzkes, MD, is the Chief of the Division of Infectious Diseases at Brigham and Women’s Hospital and is the Harriet Ryan Albee Professor of Medicine at Harvard Medical School in Boston, Massachusetts.